The PLI scheme for promotion of domestic manufacturing of critical bulk drugs is an initiative of
A. Department of Fertilizers
B. Department of Pharmaceuticals
C. Department of Chemicals and Petrochemicals
D. Department of Financial Services
Explanation:
The government of India gave approval to four waitlisted firms under the production linked incentive (PLI) scheme for domestic manufacturing of bulk drugs. The department of pharmaceuticals had launched the PLI scheme for promotion of domestic manufacturing of critical bulk drugs – Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs).
